Physician profile
Zehra A Cumber
NPI 1225051238
$1,176.67
in general payments reported to CMS, 2019-2025
9 companies · $585 in 2025
The $585 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2022: $211 · 2023: $125 · 2024: $136 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $210.51 | 2022 | |
| Abbvie INC. | $157.06 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $150.00 | 2025 | |
| Abiomed | $149.02 | 2025 | |
| Stryker Corporation | $134.81 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $125.00 | 2023 | |
| Indivior INC. | $119.98 | 2019 | |
| Edwards Lifesciences Corporation | $99.80 | 2025 | Sapien 3 Ultra Resilia |
| Bridgebio Pharma, INC. | $30.49 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zehra Cumber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.